Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Lexicon Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 123 | 1 | 112 | −10 |
| Shares | 191.3M | 27.0K | 188.8M | −2.51M (−1.3%) |
| Value | $438.2M | $61.8K | $205.8M | −$232.3M (−53.0%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 272,255 | $297.0K | 0.00% |
| Squarepoint Ops LLC | 62,243 | $67.8K | 0.00% |
| SG Americas Securities, LLC | 58,707 | $64.0K | 0.00% |
| Two Sigma Advisers, LP | 34,844 | $38.0K | 0.00% |
| Tiaa Trust, National Association | 27,000 | $29.4K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 14,239 | $16.0K | 0.00% |
| Truist Financial Corp | 12,000 | $13.1K | 0.00% |
| Chemistry Wealth Management LLC | 12,000 | $13.1K | 0.00% |
| Lindbrook Capital, LLC | 2,049 | $2.23K | 0.00% |
| Syntax Research, Inc. | 142 | $155 | 0.00% |
| JNBA Financial Advisors | 13 | $15 | 0.00% |
Sold out (21)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Fisher Asset Management, LLC | 523,394 | $1.20M |
| Ghisallo Capital Management LLC | 500,000 | $1.15M |
| AXA S.A. | 356,400 | $816.2K |
| HRT Financial LP | 198,676 | $454.0K |
| Cubist Systematic Strategies, LLC | 179,327 | $410.7K |
| Marshall Wace, LLP | 125,287 | $286.9K |
| Group One Trading, L.P. | 93,363 | $213.8K |
| Natixis Advisors, L.P. | 87,425 | $200.0K |
| Prudential Financial Inc | 51,558 | $118.1K |
| CIBC Private Wealth Group, LLC | 30,000 | $68.7K |
| State Board of Administration of Florida Retirement System | 29,400 | $67.3K |
| Nebula Research & Development LLC | 28,377 | $65.0K |
| Tucker Asset Management LLC | 27,596 | $63.2K |
| Simplex Trading, LLC | 20,926 | $47.0K |
| Virtu Financial LLC | 19,948 | $46.0K |
| Jump Financial, LLC | 19,280 | $44.2K |
| Dark Forest Capital Management LP | 15,875 | $36.4K |
| Kestra Advisory Services, LLC | 14,257 | $32.6K |
| Diametric Capital, LP | 13,988 | $32.0K |
| Pegasus Asset Management, Inc. | 10,000 | $22.9K |
| CWM, LLC | 230 | $1.00K |
Not filed for Q3 2023 yet (1)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tiaa, FSB | 27,000 | $61.8K |